Search

POLICY GOALS

[../../../../_private/schaffer_logo.htm][../../../../_private/sch_leg_op_cannabis_navbar.htm]

Chapter 2.


Given the importance which is assigned to setting clear goals
for any major social policy, it is surprising how infrequently
discussion of drug policy is preceded by a precise specification
of what the policy is intended to achieve. Too often, goals are
either global (to reduce drug use) or unattainable (to eliminate
drug use) and allow many interpretations. Similarly, goals are
often stated in such a way that they could be achieved through a
number of quite contradictory strategies and at vastly different
costs (economic, social, and personal). Only infrequently does
the discussion address the issue of the costs we are willing to
tolerate in order to achieve stated goals. Rarely is detailed
consideration given to how we might go about measuring the costs,
both of drug use itself and of attempts to control it.

In examining the range of potential regimes for the control of
cannabis use, it is important to have a clear idea of the
criteria against which we might evaluate their effects. Yet
unambiguous and meaningful statements of the objectives of
cannabis policies are difficult to find anywhere. Most official
statements about drug policy generally, and most discussions
about drug control strategies, suffer from one or more of a
number of limitations. They may fail to proffer specific goals.
They may state goals which are known to be unattainable. They may
fail to recognise the existence of multiple goals or, if they do,
they may fail to acknowledge contradictions between them or to
provide a means for assigning priorities when the goals clash.

All of these failings contribute to a policy debate which
lacks precision and intellectual rigour, and whose outcomes
depend more on rhetoric and emotion than on logical argument and
empirical data. This report starts from the proposition that it
is important to know what are the requirements for rational drug
policy in general and what are the objectives of cannabis policy
specifically. Only when these issues are articulated clearly and
can be subjected to full public scrutiny can it be said that the
cannabis policy debate has become a comprehensive and rational
one. The issues discussed in this chapter can be applied, with
suitable modifications as to specifics, to any area of drug
policy. In this chapter we do not take any position on particular
policy options. Our intention is to provide a comprehensive
framework within which any option can be evaluated.

We intend in this chapter, too, to address the issue of drug
policy, rather than drug legislation. As our discussion of
legislative options will show, similar-looking laws may have
quite different implications for cost and effectiveness depending
on the way in which they are administered. In other words, the
policy context may be more important than the legislation in
understanding the impact of a particular approach to cannabis
control. For example, in both the United States and The
Netherlands it is illegal to possess and sell personal-use
quantities of cannabis. The way in which the legislation is
interpreted and enforced, however, puts these two countries at
different ends of the cannabis policy spectrum (Wardlaw 1992).

In its turn, the policy framework adopted in any particular
country can only be understood fully if the observer is aware of
the social and political context within which social problems are
viewed, and with a knowledge of the nature and dimensions of the
drug problem in that country. Some conceptual clarifications
Kleiman and Saiger (1992) suggest that discussion of options for
drug control policy should be preceded by agreement on some basic
conceptual clarifications. These clarifications are intended to
define the nature of a satisfactory debate about drug control
options.

The following list is a modification and extension of Kleiman
and Saiger’s suggestions.

  1. Arguments that apply to the most appropriate control
    regime for one drug need not – and often do not apply to
    others. There has been considerable resistance to the
    idea that use of different drugs may best be controlled
    by different strategies. Certainly, a dominant theme in
    the drug control policies of many countries is that it is
    necessary to have consistent policies towards illicit
    drug use. It is argued that treating different illicit
    drugs differently, especially when ‚differently‘ implies
    that one drug will attract less law enforcement attention
    or less social disapproval than another, will undermine
    the general authority and credibility of anti-drug
    messages. This approach overlooks at least one important
    consideration. That is that there are a number of
    approaches to the notion of consistency. Consistency does
    not necessarily imply that we have to have a monolithic
    approach to drug problems. We can, for example, have the
    goal of reducing the harm caused by illicit drug use, but
    can achieve that goal by a number of avenues. There is no
    logical reason why these avenues have to be the same for
    all drugs, as long as we can justify why we are treating
    different drugs differently, and as long as we can
    articulate these reasons to the public. The belief that
    we must maintain a rigid adherence to one set of
    strategies for all illicit drugs ignores the reality that
    we already quite successfully accept inconsistencies and
    contradictions in drug policy across the board. The most
    obvious example is the fact that we allow a number of
    drugs, foremost amongst which are tobacco and alcohol, to
    be used legally despite their causing the same types of
    damage against which we try to protect individuals and
    society by banning the use of other drugs. There is
    general agreement that it is the goal of policy on licit
    drugs to reduce the harm caused by their use. We seek to
    achieve this by attempting to persuade people not to take
    up drug use, to decrease their consumption of these
    drugs, or to alter their manner or pattern of use.
    Although the simplest way to reduce harm would be to
    reduce the number of people using the drugs (assuming for
    the argument here that remaining users continued their
    existing consumption levels and patterns), we do not see
    attempts to get others to move to less dangerous patterns
    of use (rather than giving up use) as undermining the
    message that use of drugs is not socially desirable.
    Rather, we recognise that the overall goal of reducing
    harm can be achieved by persuading some people not to
    take up drugs, others to discontinue their use, and yet
    others to moderate their use or to change to less
    dangerous drugs or methods of administration. Strategies
    aimed at moderation are not seen as undermining
    strategies aimed at abstinence. We simply accept that
    different strategies are appropriate for different groups
    in the community and that they can all contribute to the
    overall goal of harm minimisation. There is no logical
    reason why we cannot adopt the same approach with illicit
    drugs.
  2. Drug policies should be crafted to take account of the
    different patterns and types of harms caused by specific
    drugs. Attempting to impose across-the-board strategies
    for illicit drug control in the name of consistency
    (ignoring for the moment the glaring inconsistency in not
    treating licit drug use similarly) seems to assume that
    all drug problems are, in fact, equally susceptible to
    the same measures. We know, however, that this is not the
    case. Each drug has its own consumption patterns; each
    drug harms users and others in different ways and to
    different degrees; and each has its own demand patterns,
    supply systems and market characteristics (Kleiman &
    Saiger 1992). Not only do drugs differ in these ways, but
    the same drug may exhibit different characteristics in
    different geographical, socioeconomic or cultural
    contexts (Haaga & Reuter 1990). Accordingly, it is
    not logical to expect that there will be uniform
    solutions to drug problems. ‚Consistency for the sake of
    it should not be able to stifle the ability of local
    areas, states or nations to deal with drug problems in a
    manner which is appropriate for their circumstances,
    cultural context, dimensions of the problem and so forth‘
    (Wardlaw 1992, p154). It follows that decisions about how
    best to deal with problems in relation to a specific drug
    should be made on the basis of the circumstances
    surrounding use of that drug and the practical
    possibilities for intervening in them.
  3. The details of control regimes are crucial determinants
    of their outcomes. Such details should not be left
    undefined. Much of the confusion over what is the most
    appropriate regime for the control of cannabis use stems
    from poor definition of terms such as ‚decriminalisation‘
    and ‚legalisation‘, and lack of specification of the
    details of alternative control regimes being debated. As
    the South Australian Royal Commission into the
    Non-Medical Use of Drugs ([1]South Australia 1978)
    commented, people use these terms in a variety of senses
    and are often unaware of the significant differences that
    exist between various methods of control that have been
    proposed under them. We agree with the Commission that
    these terms are not very helpful. The word
    ‚decriminalisation‘ sounds as though it refers to the
    removal of cannabis control from the criminal law. In
    practice, however, it usually refers to changes to the
    law which either allow possession of specified amounts of
    cannabis for personal consumption or reduce the penalties
    for such possession to minor fines or administrative
    sanctions involving no criminal record. As such,
    decriminalisation refers to reducing penalties, rather
    than removing them altogether ([2]Single 1989). Under
    most so-called decriminalisation proposals, dealing in
    cannabis would remain a serious criminal offence. The
    term ‚legalisation‘ presents similar difficulties. It
    covers proposals which would literally remove the drug
    from the criminal law, to those which would limit
    availability to adults (much as alcohol and tobacco are
    now regulated), to more specific proposals which would
    allow access through clinics or other health services
    only to those with established habits. Discussing
    ‚decriminalisation‘ or ‚legalisation‘ without specifying
    the details of the particular model being proposed is not
    likely to be very productive (Kleiman & Saiger 1990).
    No sensible discussion of any of the options can take
    place without specification of such details as to whom
    proposed changes would apply and under what
    circumstances, rules about advertising, place and time of
    consumption, whether or not the changes would apply to
    all preparations and forms of cannabis (or, for example,
    be restricted to those falling below a certain potency),
    and the type of regulatory arrangements which would
    replace the current law enforcement ones, together with
    details of their methods of operation and costs. ‚Such
    details should not be dismissed as easily determined or
    postponed as a problem requiring future thought‘ (Kleiman
    & Saiger 1992, p225). This report will discuss policy
    options under the broad headings suggested by the South
    Australian Royal Commission into the Non-Medical Use of
    Drugs, i.e. the total prohibition model; the
    prohibition/’civil penalty‘ model; the partial
    prohibition model; the regulatory model; and the free
    availability model ([3]South Australia 1978). Any
    analysis of control regimes should attempt to estimate
    their effects on both consumption levels and patterns of
    use. A major concern about any lessening of the current
    controls on cannabis is that it might lead to increases
    in consumption. While this is a serious concern, it is
    not the only dimension which needs to be monitored. It is
    also important to estimate how patterns of consumption
    might change under different control options. For
    example, if numbers of users rose slightly, but
    consumption per person fell, or less dangerous forms of
    the drug were used, or less harmful methods of use were
    employed, the overall amount of harm occasioned might be
    reduced and the policy might be judged more successful
    than the status quo. Similarly, if under one option, it
    seemed that numbers of users might fall, but that heavier
    use patterns would emerge, or more potent forms of the
    drug would become more popular, the option might be
    judged less desirable, even though a decrease in numbers
    of users had been achieved.
  4. Control regimes should not be considered in isolation
    from the problems of implementation and enforcement. In
    attempting to predict the outcomes for users of various
    alternatives to the current methods of cannabis control,
    it is important to specify the costs and problems of
    regulation that would accompany them. In all options
    which have any political reality there remains the need
    to licence, to tax or to regulate to ensure that
    restrictions are observed on such things as sale to
    minors, use in conjunction with the operation of vehicles
    or machinery, potency levels, amounts purchased etc. The
    costs and practical problems of implementation should be
    included in any debate about control options.
  5. Arguments about consequences of drug use should be
    separated from arguments about morals. Much confusion has
    been engendered in the drug policy debate because of a
    failure to separate the negative consequences of drug use
    from moral considerations. It is quite legitimate for a
    community to invoke moral arguments in determining the
    proper course of drug policy (Wilson 1990). But it must
    be clear that the arguments are moral ones, not morality
    disguised as concern over consequences. If opposition to
    cannabis use is based on the view that it is illegitimate
    to use a drug to alter one’s perception, to seek pleasure
    or to become intoxicated (a moral argument), then it
    should be clearly stated as such so that the proposition
    can be debated in those terms. It confuses the issue and
    injects unproductive emotion into the argument if that
    concern is disguised by reference to the harms caused by
    cannabis use. These need also to be debated separately.
    We need to know whether there would still be opposition
    to cannabis use on moral grounds even if we could
    eliminate the health costs.
  6. Options should be evaluated on the basis of evidence of
    damage. We should require that policies that seek to
    impose expensive control regimes on any drug be based on
    evidence of harm occasioned by use of the drug. The cost
    and restrictiveness of the control regime should be
    clearly related to the damage caused by use of the drug,
    and there should be empirical evidence of the type and
    extent of the damage.
  7. Any policy should recognise the changing nature of the
    drug problem and be able to change with it. Additionally,
    all policies should be reviewed periodically to ensure
    that they are still relevant to current circumstances. A
    major drawback to current approaches to drug policy is
    that they are generally poor at adapting to changes in
    the nature of the drug problem or to changes in our
    levels of knowledge and understanding of drug use
    processes and patterns and their interactions with
    different control strategies. All policies should have
    in-built capacity for evaluation to enable them to be
    adjusted in a timely manner to emerging patterns of use
    or changes in our understanding of the problem.
  8. Policy should be made in the light of the costs of
    control as well as the benefits. Discussion of any policy
    option should clearly identify any costs associated with
    it. An attempt should be made to inventory all of the
    direct and indirect costs associated with the option,
    including social costs. It is particularly important to
    include any unintended consequences predicted or
    discovered. For example, what are the substitution
    effects of a particular policy (does enforcement success,
    for example, result in fewer users or do the users turn
    to other, more dangerous drugs)?
  9. The goals of drug policy should be realistic. Enunciating
    unrealistic goals for drug policy can have a number of
    negative consequences. Foremost amongst these are the
    undermining of the credibility of the policy and the
    justification of extreme methods in their pursuit
    (Wardlaw 1992).
  10. Discussion of policy options should include a
    specification of which harms they are intended to reduce.
    Specifying the harms intended to be reduced by the
    overall policy and the options within it clarifies
    thinking about goals and provides a necessary basis for
    evaluation. If possible, effects should also be discussed
    according to the dimensions of time (short-, medium-, and
    long-term effects), duration (temporary or permanent),
    and scale (minor, moderate, or major).
  11. Discussion of cannabis policy (and drug policy generally)
    should recognise the existence of multiple and sometimes
    contradictory goals. It may be necessary to choose
    explicitly between goals, to assign them to a hierarchy,
    or to accept that different goals (and, therefore,
    different strategies and programs) may be appropriate for
    different sub-populations or areas. Examples include
    accepting that it is appropriate to teach established
    users safer methods of use while trying to discourage
    other groups from starting use, or police not arresting
    cannabis users because it is considered to impose an
    unwarranted burden on the court and corrections systems.
  12. Policies to discourage cannabis use should be shown to be
    effective or be changed. Sound social policy should be
    robust enough to withstand critical scrutiny. The costs
    of current approaches to cannabis control are
    considerable and their continuation should be guaranteed
    only if data can be provided which demonstrate their
    effectiveness. The same criterion should be applied to
    any alternative approach.
  13. The harms caused by the control regimes themselves should
    not outweigh the harms prevented by them. It is very
    difficult to measure accurately the costs both of
    cannabis use and of efforts to prevent it. Nevertheless,
    it is not good enough merely to assert that a policy is
    the correct one, or to fail to investigate alternatives
    when there is evidence of ineffectiveness (the large
    number of users) and cost (the cost of law enforcement,
    the intrusions on civil liberties, violence and
    corruption caused by forcing sales onto a black market,
    and so on). Any social policy should be reviewed when
    there is reason to believe that the costs of
    administering it outweigh the harms reduced. The goals of
    cannabis policy In deciding upon the appropriate model to
    adopt to control cannabis use, it is necessary to specify
    the goals of the policy, as they will constitute the
    criteria against which selection will be made (and
    against which eventual evaluation of performance will be
    made). The following list comprises possible goals which
    have been mentioned in the literature on cannabis policy.
    It is intended as illustrative of the range of goals
    which might be considered and is not a set of goals
    proposed by this report:
  • to reduce the total amount of cannabis consumed;
  • to reduce use among young people;
  • to reduce the supply of cannabis to the market;
  • to increase the cost of cannabis to the buyer;
  • to increase the probability of arrest for a cannabis
    offence;
  • to promote safer methods of consumption of cannabis;
  • to limit use of cannabis to smaller amounts;
  • to limit sales of cannabis to specialist sellers (and not
    to have it sold by dealers in other, more dangerous,
    drugs, for example);
  • to limit progression from cannabis use to use of other
    drugs;
  • to serve as a symbol of community disapproval of drug
    use;
  • to limit the amount of violence in the cannabis
    distribution system; and
  • to limit the substitution of other (more damaging) drugs
    for cannabis.

This list is not intended to be comprehensive. It is merely
indicative of the range and detail which needs to be considered
when deciding on policy directions and on the resulting
legislation and implementation strategies. Examination of such a
list makes a number of things apparent. One of these is that to
make sense of it requires the assignment of priorities.
Priorities may be of two types. The first is simply to assign a
ranking in order of importance as judged by some defined
criteria. This is useful when attempting to assign resources to
different parts of a total strategy. A consideration which may
also play a part here is the impact that a particular strategy is
estimated to be capable of having. The second involves deciding
between two or more conflicting goals. Considerations here are
likely to include harms caused or prevented, as well as
considerations such as cost and effectiveness. Laying out goals
in this fashion also alerts us to the need for high quality data
for decision-making, and to the need for sound evaluation
methodologies to be able to measure the impact of our policies
and their resulting implementation strategies. Examination of the
list above makes it immediately apparent that extensive empirical
data are required to be able to assign priorities and measure
impacts. The list also provides a practical example of the sorts
of considerations which policy makers should include in their
deliberations as they attempt to apply the conceptual tools
discussed earlier in this chapter.

References

Haaga, J. & Reuter, P. 1990, ‚The limits of the Czar’s
ukase: drug policy at the local level‘, Yale Law and Policy
Review, vol. 8, no. 1, pp36-74.

Kleiman, M. & Saiger, A. 1992, ‚Taxes, regulations and
prohibitions: Reformulating the legalization debate‘, in Drug
Policy in the Americas, ed. P. Smith, Westview Press, Boulder.

Kleiman, M. & Saiger, A. 1990, ‚Drug legalization: the
importance of asking the right question‘, Hofstra Law Review,
vol. 18, pp527-565.

Single, E. 1989, ‚The impact of marijuana decriminalization:
an update‘, Journal of Public Health Policy, vol. 10, no. 4,
pp456-466.

South Australia. Royal Commission into the Non-Medical Use of
Drugs 1978, Cannabis: A Discussion Paper, South Australian
Government, Adelaide.

Wardlaw, G. 1992, ‚Discussion‘, in M. Bull, D. McDowell, J.
Norberry, H. Strang & G. Wardlaw, Comparative Analysis of
Drug Strategy, NCADA Monograph Series No. 18, AGPS, Canberra.

Wilson, J.Q. 1990, ‚Drugs and crime‘, in Drugs and Crime:
Crime and Justice: A Review of Research, vol. 13, eds M. Tonry
& J.Q. Wilson, University of Chicago Press, Chicago.


[../../../../_private/sch_leg_op_cannabis_navbar.htm]

 

 

Schreibe einen Kommentar